The Brutalist Report - CNBC
- Alphabet calls out new AI-related risks, as it taps debt market to fund buildout [15d]
- Tulsi Gabbard to testify at Senate Intelligence Committee amid election probe concerns [15d]
- Housing affordability package set to advance in Congress amid home-cost concerns [15d]
- Morgan Stanley says buy 2 beaten-down software stocks. We agree on one of them [15d]
- Target steps up investment in store staffing, cuts about 500 other roles to help fix customer experience [15d]
- Our basket of stocks that benefit from higher spending on AI is up again [15d]
- Under the hood of the AI economy with Databricks CEO Ali Ghodsi [15d]
- What's driving Procter & Gamble's monster start to 2026 — and how it can continue [15d]
- Student loan complaints hit record high, CFPB finds — but the watchdog agency omits details [15d]
- FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims [15d]
- This ancillary AI stock hits another record high. How we're playing the rally [15d]
- Following Super Bowl ad, Trump accounts launch a new sign-up option [15d]
- Short-seller CapitalWatch apologizes, retracts report on AppLovin shareholder [15d]
- Monday.com drops 19% as AI disruption fears mount in software [15d]
- Some student loan borrowers wait over a year in public servant debt forgiveness backlog [15d]
- Databricks completes $5 billion funding round at $134 billion valuation [15d]
- Workday CEO Carl Eschenbach is stepping down, co-founder Aneel Bhusri to take over [15d]
- How to read people and master your body language to be more influential at work [15d]
- Hamptons real estate prices hit record, with 2026 summer rentals going fast [15d]
- Meta starts big week in court, with opening arguments beginning in New Mexico, LA trials [15d]
- Sam Altman touts ChatGPT's reaccelerating growth to employees as OpenAI closes in on $100 billion funding [15d]
- Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections [15d]
Previous Day